|
|
||||||||


* Division of Kinesiology, Department of Social and Preventive Medicine, Faculty of Medicine, Laval University, Ste-Foy, Quebec;
Department of Biochemistry, Faculty of Medical Sciences, University of Nijmegen, Nijmegen, The Netherlands;
Department of Exercise Sciences, University of Southern California, Los Angeles, California; and Division of Endocrinology and Metabolism, and
§ Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
2Correspondence: East-1140 Biomedical Science Tower, University of Pittsburgh, Pittsburgh, PA 15213, USA. E-mail: Kelley{at}msx.dept.-med.pitt.edu
A number of biochemical defects have been identified in glucose metabolism within skeletal muscle in obesity, and positive effects of weight loss on insulin resistance are also well established. Less is known about the capacity of skeletal muscle for the metabolism of fatty acids in obesity-related insulin resistance and of the effects of weight loss, though it is evident that muscle contains increased triglyceride. The current study was therefore undertaken to profile markers of human skeletal muscle for fatty acid metabolism in relation to obesity, in relation to the phenotype of insulin-resistant glucose metabolism, and to examine the effects of weight loss. Fifty-five men and women, lean and obese, with normal glucose tolerance underwent percutaneous biopsy of vastus lateralis skeletal muscle for determination of HADH, CPT, heparin-releasable (Hr) and tissue-extractable (Ext) LPL, CS, COX, PFK, and GAPDH enzyme activities, and content of cytosolic and plasma membrane FABP. Insulin sensitivity was measured using the euglycemic clamp method. DEXA was used to measure FM and FFM. In skeletal muscle of obese individuals, CPT, CS, and COX activities were lower while, conversely, they had a higher or similar content of FABPC and FABPPM than in lean individuals. Hr and Ext LPL activities were similar in both groups. In multivariate and simple regression analyses, there were significant correlations between insulin resistance and several markers of FA metabolism, notably, CPT and FABPPM. These data suggest that in obesity-related insulin resistance, the metabolic capacity of skeletal muscle appears to be organized toward fat esterification rather than oxidation and that dietary-induced weight loss does not correct this disposition.Simoneau, J.-A., Veerkamp, J. H., Turcotte, L. P., Kelley, D. E. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss.
Key Words: carnitine palmitoyl transferase fatty acid binding proteins lipoprotein lipase maximal aerobic power fatty acid oxidation
This article has been cited by other articles:
![]() |
M. M. Rogge The Role of Impaired Mitochondrial Lipid Oxidation in Obesity Biol Res Nurs, April 1, 2009; 10(4): 356 - 373. [Abstract] [PDF] |
||||
![]() |
S. Bokhari, P. Emerson, Z. Israelian, A. Gupta, and C. Meyer Metabolic fate of plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further early defects in the pathogenesis of type 2 diabetes Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E440 - E444. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Laye, R. S. Rector, S. J. Borengasser, S. P. Naples, G. M. Uptergrove, J. A. Ibdah, F. W. Booth, and J. P. Thyfault Cessation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue J Appl Physiol, January 1, 2009; 106(1): 161 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Galgani, C. Moro, and E. Ravussin Metabolic flexibility and insulin resistance Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1009 - E1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Tardy, C. Giraudet, P. Rousset, J.-P. Rigaudiere, B. Laillet, S. Chalancon, J. Salles, O. Loreau, J.-M. Chardigny, and B. Morio Effects of trans MUFA from dairy and industrial sources on muscle mitochondrial function and insulin sensitivity J. Lipid Res., July 1, 2008; 49(7): 1445 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G.S. Toledo, E. V. Menshikova, K. Azuma, Z. Radikova, C. A. Kelley, V. B. Ritov, and D. E. Kelley Mitochondrial Capacity in Skeletal Muscle Is Not Stimulated by Weight Loss Despite Increases in Insulin Action and Decreases in Intramyocellular Lipid Content Diabetes, April 1, 2008; 57(4): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Berggren, K. E. Boyle, W. H. Chapman, and J. A. Houmard Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E726 - E732. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Houmard Intramuscular lipid oxidation and obesity Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1111 - R1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Civitarese and E. Ravussin Minireview: Mitochondrial Energetics and Insulin Resistance Endocrinology, March 1, 2008; 149(3): 950 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-a Kim, Y. Wei, and J. R. Sowers Role of Mitochondrial Dysfunction in Insulin Resistance Circ. Res., February 29, 2008; 102(4): 401 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moro, S. Bajpeyi, and S. R. Smith Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E203 - E213. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Noland, T. L. Woodlief, B. R. Whitfield, S. M. Manning, J. R. Evans, R. W. Dudek, R. M. Lust, and R. N. Cortright Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E986 - E1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Demars, J. Riquet, M.-P. Sanchez, Y. Billon, J.-F. Hocquette, B. Lebret, N. Iannuccelli, J.-P. Bidanel, D. Milan, and F. Gondret Metabolic and histochemical characteristics of fat and muscle tissues in homozygous or heterozygous pigs for the body composition QTL located on chromosome 7 Physiol Genomics, August 20, 2007; 30(3): 232 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Turner, C. R. Bruce, S. M. Beale, K. L. Hoehn, T. So, M. S. Rolph, and G. J. Cooney Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle: Evidence Against a Role for Reduced Fatty Acid Oxidation in Lipid-Induced Insulin Resistance in Rodents Diabetes, August 1, 2007; 56(8): 2085 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Houmard Do the mitochondria of obese individuals respond to exercise training? J Appl Physiol, July 1, 2007; 103(1): 6 - 7. [Full Text] [PDF] |
||||
![]() |
E. V. Menshikova, V. B. Ritov, R. E. Ferrell, K. Azuma, B. H. Goodpaster, and D. E. Kelley Characteristics of skeletal muscle mitochondrial biogenesis induced by moderate-intensity exercise and weight loss in obesity J Appl Physiol, July 1, 2007; 103(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Noland, J. P. Thyfault, S. T. Henes, B. R. Whitfield, T. L. Woodlief, J. R. Evans, J. A. Lust, S. L. Britton, L. G. Koch, R. W. Dudek, et al. Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E31 - E41. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mogensen, K. Sahlin, M. Fernstrom, D. Glintborg, B. F. Vind, H. Beck-Nielsen, and K. Hojlund Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes Diabetes, June 1, 2007; 56(6): 1592 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Holloway, A. B. Thrush, G. J. F. Heigenhauser, N. N. Tandon, D. J. Dyck, A. Bonen, and L. L. Spriet Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1782 - E1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Magkos, B. W. Patterson, B. S. Mohammed, S. Klein, and B. Mittendorfer Women Produce Fewer but Triglyceride-Richer Very Low-Density Lipoproteins than Men J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1311 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nisoli, E. Clementi, M. O. Carruba, and S. Moncada Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome? Circ. Res., March 30, 2007; 100(6): 795 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sebastian, L. Herrero, D. Serra, G. Asins, and F. G. Hegardt CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E677 - E686. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sirikul, B. A. Gower, G. R. Hunter, D. E. Larson-Meyer, and B. R. Newcomer Relationship between insulin sensitivity and in vivo mitochondrial function in skeletal muscle Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E724 - E728. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Smith and G. E. O. Muscat Orphan nuclear receptors: therapeutic opportunities in skeletal muscle Am J Physiol Cell Physiol, August 1, 2006; 291(2): C203 - C217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schenk and J. F. Horowitz Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E254 - E260. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tiffin, E. Adie, F. Turner, H. G. Brunner, M. A. van Driel, M. Oti, N. Lopez-Bigas, C. Ouzounis, C. Perez-Iratxeta, M. A. Andrade-Navarro, et al. Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes Nucleic Acids Res., June 6, 2006; 34(10): 3067 - 3081. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lopez-Soriano, C. Chiellini, M. Maffei, P. A. Grimaldi, and J. M. Argiles Roles of Skeletal Muscle and Peroxisome Proliferator-Activated Receptors in the Development and Treatment of Obesity Endocr. Rev., May 1, 2006; 27(3): 318 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oberbach, Y. Bossenz, S. Lehmann, J. Niebauer, V. Adams, R. Paschke, M. R. Schon, M. Bluher, and K. Punkt Altered Fiber Distribution and Fiber-Specific Glycolytic and Oxidative Enzyme Activity in Skeletal Muscle of Patients With Type 2 Diabetes Diabetes Care, April 1, 2006; 29(4): 895 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Berria, L. Wang, D. K. Richardson, J. Finlayson, R. Belfort, T. Pratipanawatr, E. A. De Filippis, S. Kashyap, and L. J. Mandarino Increased collagen content in insulin-resistant skeletal muscle Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E560 - E565. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kiens Skeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance Physiol Rev, January 1, 2006; 86(1): 205 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bach, D. Naon, S. Pich, F. X. Soriano, N. Vega, J. Rieusset, M. Laville, C. Guillet, Y. Boirie, H. Wallberg-Henriksson, et al. Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle: Effects of Type 2 Diabetes, Obesity, Weight Loss, and the Regulatory Role of Tumor Necrosis Factor {alpha} and Interleukin-6 Diabetes, September 1, 2005; 54(9): 2685 - 2693. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Cha, T. P. Ciaraldi, K.-S. Park, L. Carter, S. R. Mudaliar, and R. R. Henry Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPAR{gamma} agonists Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E151 - E159. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ribalta, C. J.M. Halkes, J. Salazar, L. Masana, and M. C. Cabezas Additive Effects of the PPAR{gamma}, APOE, and FABP-2 Genes in Increasing Daylong Triglycerides of Normolipidemic Women to Concentrations Comparable to Those in Men Clin. Chem., May 1, 2005; 51(5): 864 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Kase, A. J. Wensaas, V. Aas, K. Hojlund, K. Levin, G. H. Thoresen, H. Beck-Nielsen, A. C. Rustan, and M. Gaster Skeletal Muscle Lipid Accumulation in Type 2 Diabetes May Involve the Liver X Receptor Pathway Diabetes, April 1, 2005; 54(4): 1108 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Menshikova, V. B. Ritov, F. G. S. Toledo, R. E. Ferrell, B. H. Goodpaster, and D. E. Kelley Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E818 - E825. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Park, G. H. Choi, H. I. Choi, J. Ryu, C. Y. Jung, and W. Lee Depletion of Mitochondrial DNA Causes Impaired Glucose Utilization and Insulin Resistance in L6 GLUT4myc Myocytes J. Biol. Chem., March 18, 2005; 280(11): 9855 - 9864. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schenk, J. N. Cook, A. E. Kaufman, and J. F. Horowitz Postexercise insulin sensitivity is not impaired after an overnight lipid infusion Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E519 - E525. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Ritov, E. V. Menshikova, J. He, R. E. Ferrell, B. H. Goodpaster, and D. E. Kelley Deficiency of Subsarcolemmal Mitochondria in Obesity and Type 2 Diabetes Diabetes, January 1, 2005; 54(1): 8 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yang, J. S. Kays, T. R. Skillman, L. Burris, T. W. Seng, and C. Hammond C75 [4-Methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic Acid] Activates Carnitine Palmitoyltransferase-1 in Isolated Mitochondria and Intact Cells without Displacement of Bound Malonyl CoA J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Castellani, P. Gargalovic, M. Febbraio, S. Charugundla, M.-L. Jien, and A. J. Lusis Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II J. Lipid Res., December 1, 2004; 45(12): 2377 - 2387. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pruchnic, A. Katsiaras, J. He, D. E. Kelley, C. Winters, and B. H. Goodpaster Exercise training increases intramyocellular lipid and oxidative capacity in older adults Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E857 - E862. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. He and D. E. Kelley Muscle glycogen content in type 2 diabetes mellitus Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E1002 - E1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kiens, C. Roepstorff, J. F. C. Glatz, A. Bonen, P. Schjerling, J. Knudsen, and J. N. Nielsen Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender J Appl Physiol, October 1, 2004; 97(4): 1209 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Petibois, A. Cassaigne, H. Gin, and G. Deleris Lipid Profile Disorders Induced by Long-Term Cessation of Physical Activity in Previously Highly Endurance-Trained Subjects J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3377 - 3384. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Iozzo, A. K. Turpeinen, T. Takala, V. Oikonen, J. Bergman, T. Gronroos, E. Ferrannini, P. Nuutila, and J. Knuuti Defective Liver Disposal of Free Fatty Acids in Patients with Impaired Glucose Tolerance J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3496 - 3502. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Perdomo, S. R. Commerford, A.-M. T. Richard, S. H. Adams, B. E. Corkey, R. M. O'Doherty, and N. F. Brown Increased {beta}-Oxidation in Muscle Cells Enhances Insulin-stimulated Glucose Metabolism and Protects against Fatty Acid-induced Insulin Resistance Despite Intramyocellular Lipid Accumulation J. Biol. Chem., June 25, 2004; 279(26): 27177 - 27186. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schrauwen and M. K.C. Hesselink Oxidative Capacity, Lipotoxicity, and Mitochondrial Damage in Type 2 Diabetes Diabetes, June 1, 2004; 53(6): 1412 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fabris, G. Mingrone, G. Milan, M. Manco, M. Granzotto, A. D. Pozza, A. Scarda, R. Serra, A. V. Greco, G. Federspil, et al. Further Lowering of Muscle Lipid Oxidative Capacity in Obese Subjects after Biliopancreatic Diversion J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1753 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bruce, M. J. Anderson, A. L. Carey, D. G. Newman, A. Bonen, A. D. Kriketos, G. J. Cooney, and J. A. Hawley Muscle Oxidative Capacity Is a Better Predictor of Insulin Sensitivity than Lipid Status J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5444 - 5451. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Doucet, A. Tremblay, J.-A. Simoneau, and D. R Joanisse Skeletal muscle enzymes as predictors of 24-h energy metabolism in reduced-obese persons Am. J. Clinical Nutrition, September 1, 2003; 78(3): 430 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bruce, A. L. Carey, J. A. Hawley, and M. A. Febbraio Intramuscular Heat Shock Protein 72 and Heme Oxygenase-1 mRNA Are Reduced in Patients With Type 2 Diabetes: Evidence That Insulin Resistance Is Associated With a Disturbed Antioxidant Defense Mechanism Diabetes, September 1, 2003; 52(9): 2338 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Short, J. L. Vittone, M. L. Bigelow, D. N. Proctor, R. A. Rizza, J. M. Coenen-Schimke, and K. S. Nair Impact of Aerobic Exercise Training on Age-Related Changes in Insulin Sensitivity and Muscle Oxidative Capacity Diabetes, August 1, 2003; 52(8): 1888 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Patti, A. J. Butte, S. Crunkhorn, K. Cusi, R. Berria, S. Kashyap, Y. Miyazaki, I. Kohane, M. Costello, R. Saccone, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 PNAS, July 8, 2003; 100(14): 8466 - 8471. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Stump, K. R. Short, M. L. Bigelow, J. M. Schimke, and K. S. Nair Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts PNAS, June 24, 2003; 100(13): 7996 - 8001. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Gray, C. J. Tanner, W. J. Pories, K. G. MacDonald, and J. A. Houmard Effect of weight loss on muscle lipid content in morbidly obese subjects Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E726 - E732. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mittendorfer, B. W Patterson, and S. Klein Effect of sex and obesity on basal VLDL-triacylglycerol kinetics Am. J. Clinical Nutrition, March 1, 2003; 77(3): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Kelley, J. He, E. V. Menshikova, and V. B. Ritov Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes Diabetes, October 1, 2002; 51(10): 2944 - 2950. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Halvatsiotis, K. R. Short, M. Bigelow, and K. S. Nair Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes Diabetes, August 1, 2002; 51(8): 2395 - 2404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Brand-Miller, S. H. Holt, D. B Pawlak, and J. McMillan Glycemic index and obesity Am. J. Clinical Nutrition, July 1, 2002; 76(1): 281S - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Steinberg, M. L. Parolin, G. J. F. Heigenhauser, and D. J. Dyck Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E187 - E192. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Tanner, H. A. Barakat, G. L. Dohm, W. J. Pories, K. G. MacDonald, P. R. G. Cunningham, M. S. Swanson, and J. A. Houmard Muscle fiber type is associated with obesity and weight loss Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1191 - E1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Steinberg, D. J. Dyck, J. Calles-Escandon, N. N. Tandon, J. J. F. P. Luiken, J. F. C. Glatz, and A. Bonen Chronic Leptin Administration Decreases Fatty Acid Uptake and Fatty Acid Transporters in Rat Skeletal Muscle J. Biol. Chem., March 8, 2002; 277(11): 8854 - 8860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Franch, J. Knudsen, B. A. Ellis, P. K. Pedersen, G. J. Cooney, and J. Jensen Acyl-CoA Binding Protein Expression Is Fiber Type- Specific and Elevated in Muscles From the Obese Insulin-Resistant Zucker Rat Diabetes, February 1, 2002; 51(2): 449 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Goodpaster, J. He, S. Watkins, and D. E. Kelley Skeletal Muscle Lipid Content and Insulin Resistance: Evidence for a Paradox in Endurance-Trained Athletes J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5755 - 5761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Dyck, G. Steinberg, and A. Bonen Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E600 - E607. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Turcotte, J. R. Swenberger, M. Zavitz Tucker, and A. J. Yee Increased Fatty Acid Uptake and Altered Fatty Acid Metabolism in Insulin-Resistant Muscle of Obese Zucker Rats Diabetes, June 1, 2001; 50(6): 1389 - 1396. [Abstract] [Full Text] |
||||
![]() |
D. E. Kelley and B. H. Goodpaster Skeletal Muscle Triglyceride: An aspect of regional adiposity and insulin resistance Diabetes Care, May 1, 2001; 24(5): 933 - 941. [Abstract] [Full Text] |
||||
![]() |
E. E. Blaak, B. H. R. Wolffenbuttel, W. H. M. Saris, M. M. A. L. Pelsers, and A. J. M. Wagenmakers Weight Reduction and the Impaired Plasma-Derived Free Fatty Acid Oxidation in Type 2 Diabetic Subjects J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1638 - 1644. [Abstract] [Full Text] |
||||
![]() |
J. He, S. Watkins, and D. E. Kelley Skeletal Muscle Lipid Content and Oxidative Enzyme Activity in Relation to Muscle Fiber Type in Type 2 Diabetes and Obesity Diabetes, April 1, 2001; 50(4): 817 - 823. [Abstract] [Full Text] |
||||
![]() |
P. Malenfant, A. Tremblay, E. Doucet, P. Imbeault, J.-A. Simoneau, and D. R. Joanisse Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E632 - E639. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Dobbins, L. S. Szczepaniak, B. Bentley, V. Esser, J. Myhill, and J. D. McGarry Prolonged Inhibition of Muscle Carnitine Palmitoyltransferase-1 Promotes Intramyocellular Lipid Accumulation and Insulin Resistance in Rats Diabetes, January 1, 2001; 50(1): 123 - 130. [Abstract] [Full Text] |
||||
![]() |
P. Imbeault, A. Tremblay, J.-A. Simoneau, and D. R. Joanisse Weight loss-induced rise in plasma pollutant is associated with reduced skeletal muscle oxidative capacity Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E574 - E579. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |